Metastatic Solid Tumor Clinical Trials in Salt Lake City, Utah
4 studies are recruiting for metastatic solid tumor in Salt Lake City, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah
- Locations
- 39 in total
- Run by
- Eli Lilly and Company
-
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
This study will evaluate the safety, tolerability, and efficacy of DS-3939a in participants with advanced solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
- Locations
- 36 in total
- Run by
- Daiichi Sankyo
-
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
- Locations
- 30 in total
- Run by
- Coherus Oncology, Inc.
-
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
The goal of this clinical trial is to learn if using topical tretinoin will help patients with solid tumors who are experiencing an acneiform rash as a side effect of their treatment. Researchers will compare the use of tretinoin on one side of the face to the use of a placebo on the other side of …
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah
- Run by
- University of Utah
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.